Saint-Gobain adds high purity option to Sani-Tech line

Published: 24-Jan-2012
Manufacturing

Ultra-HP combines reinforced outer jacket with fully bonded FEP liner

Saint-Gobain has added the Sani-Tech Ultra-HP high purity hose to its Sani-Tech line of fluid transfer products.

Ultra-HP combines a tough outer jacket and hose comprising multiple layers of Sani-Tech Ultra platinum-cured silicone and 316L stainless steel helical wire reinforcement with a PharmaFluor FEP liner. The liner's smooth inner bore surface provides both optimal flow and ease of cleaning and sanitisation.

The PharmaFluor FEP liner is said to minimise bonding of biological materials and maintains fluid purity due to low TOCs, extractables and leachables. The liner is fully bonded to the silicone hose using a patented bonding technology, which helps ensure a high purity fluid path.

The company says the hose's overall light weight, low force to bend and exceptional flexibility make it suitable for a variety of applications, including bioprocessing, load cells, product transfer and steam-in-place/clean-in-place (SIP/CIP).

Sani-Tech Ultra-HP hose is made from USP Class VI compliant materials and certified to meet USP <88>, USP <87>, EP 3.1.9, ISO 10993, FDA 21 CFR 177.2600 and FDA 21 CFR 177.1550 requirements.

See more

You may also like

Design & Build

Saint-Gobain completes Florida stage of global manufacturing expansion

Read more
French manufacturer is spending $77.5m on a global component manufacturing expansion programme spanning seven sites

Trending Articles

  1. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  2. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  3. Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Executive with over 20 years of management experience to lead pharmaceutical packaging and delivery systems company
  4. Abzena and Mabqi announce strategic partnership to offer integrated discovery through development solution This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    The cross-pollination effect: how shared learnings bear fruit for drug sponsors This article explores how contract development and manufacturing organisations leverage the cross-pollination of knowledge to help drug sponsors overcome critical challenges in pharmaceutical development

You may also like

Design & Build

Saint-Gobain completes Florida stage of global manufacturing expansion

French manufacturer is spending $77.5m on a global component manufacturing expansion programme spanning seven sites
Manufacturing

Saint-Gobain Performance Plastics acquires Applied Bioprocess Containers

Taking advantage of its expertise in the design and manufacture of bioprocess containers
Manufacturing

Saint-Gobain Sani-Tech Ultra tubing delivers improved performance

Saint-Gobain Performance Plastics in the US has added Sani-Tech Ultra platinum-cured silicone tubing to its portfolio
Manufacturing

Pioneering Peptide-Builder debuts at UEA

Vapourtec kept it local with the first ever installation of their pioneering production Peptide-Builder system taking place at the University of East Anglia (UEA) in Norwich
Manufacturing

Moderna invests $140m to onshore drug product manufacturing and complete US end-to-end mRNA network

Moderna is expanding its Norwood, Massachusetts site to bring drug product manufacturing in-house, creating hundreds of biomanufacturing jobs and establishing full domestic, end-to-end production for its mRNA vaccines and therapeutics by 2027
Manufacturing

GEA to showcase Rockwell Automation-Compatible GEA kytero 2000 Single-Use Separator at Automation Fair 2025

As a gold-level OEM member of the Rockwell PartnerNetwork™, GEA is strengthening its collaboration with Rockwell by offering full compatibility between the kytero® 2000 and Rockwell’s latest hardware and software suite
Manufacturing

SU Puresonic ultrasonic sensor ensures precise hygienic flow measurement

Innovative design meets the highest standards in food, pharma, and water treatment
Subscribe now